Adaptive-like functions of NK cells have been extensively studied in the context of human cytomegalovirus (HCMV) infection, particularly for NKG2C+ NK cells. The NKG2A inhibitory and the NKG2C activating receptors share a common ligand, the HLA-E molecule, and can be co-expressed in a unique NK cell subset. However, key characteristics and memory response capacity of this subset remain unclear. We analyzed the proliferative responses, functional attributes and transcriptional signatures of NKG2C+NKG2A+ subsets within CD57+ and CD57− fractions of peripheral blood CD56dimNK cells by comparing them with NKG2A− counterparts. Double-positive NK cells displayed a less mature phenotype, increased MHC-II and exhibited transcriptome profile indicating enhanced adhesion/migration capacities with no difference in adaptive state associated genes expression. These cells showed enhanced proliferation compared to NKG2A− cells, which was not reduced upon interaction with HLA-E presenting the HCMV (VMAPRTLFL, LFL) peptide. CD57+NKG2C+NKG2A+ subset showed enhanced antibody-dependent IFNγ production. Expanded upon LFL stimulation this subset again exhibited enhanced IFNγ production capacity along with peptide-specific mRNA expression profile, demonstrating an adaptive-like response. These results provide additional insight into the diversity of HCMV-specific NK cell subsets, highlighting NKG2A+NKG2C+ NK cells’ immunotherapeutical potential.
No takes yet. Share an insight, caveat, or question.
Alekseeva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: